Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsNASALGeneric

CROMOLYN SODIUM

CROMOLYN SODIUM

Standard Dose
5.2MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CROMOLYN SODIUM is listed in Drugs@FDA under application 077976 (ANDA).

Marketing status: Discontinued Active ingredient CROMOLYN SODIUM Form and strength SPRAY, METERED;NASAL - 5.2MG/SPRAY Sponsor HH AND P Submission history Latest submission status date: 2007-09-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview CROMOLYN SODIUM is listed in Drugs@FDA under application 077976 (ANDA). Marketing status: Discontinued Active ingredient CROMOLYN SODIUM Form and strength SPRAY, METERED;NASAL - 5.2MG/SPRAY Sponsor HH AND P Submission history Latest submission status date: 2007-09-07 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.